Abstract |
|
Authors | Li-Hua Chen, Jing Fang, Huaixing Li, Wendy Demark-Wahnefried, Xu Lin |
Journal | Molecular cancer therapeutics
(Mol Cancer Ther)
Vol. 6
Issue 9
Pg. 2581-90
(Sep 2007)
ISSN: 1535-7163 [Print] United States |
PMID | 17876055
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Lignans
- Phytoestrogens
- Tumor Suppressor Protein p53
- Cytochromes c
- MDM2 protein, human
- Proto-Oncogene Proteins c-mdm2
- Poly(ADP-ribose) Polymerases
- GSK3B protein, human
- Glycogen Synthase Kinase 3 beta
- Proto-Oncogene Proteins c-akt
- Glycogen Synthase Kinase 3
- Caspases
- 4-Butyrolactone
- 2,3-bis(3'-hydroxybenzyl)butyrolactone
|
Topics |
- 4-Butyrolactone
(analogs & derivatives, pharmacology)
- Apoptosis
(drug effects)
- Caspases
(metabolism)
- Cell Survival
(drug effects)
- Cytochromes c
(metabolism)
- Enzyme Activation
(drug effects)
- Glycogen Synthase Kinase 3
(metabolism)
- Glycogen Synthase Kinase 3 beta
- Humans
- Immunoblotting
- In Situ Nick-End Labeling
- Lignans
(pharmacology)
- Male
- Membrane Potential, Mitochondrial
(drug effects)
- Mitochondria
(drug effects, metabolism)
- Phytoestrogens
(pharmacology)
- Poly(ADP-ribose) Polymerases
(metabolism)
- Prostatic Neoplasms
(drug therapy, metabolism, pathology)
- Proto-Oncogene Proteins c-akt
(metabolism)
- Proto-Oncogene Proteins c-mdm2
(metabolism)
- Tumor Cells, Cultured
(drug effects, metabolism)
- Tumor Suppressor Protein p53
(metabolism)
|